Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Ceptava 180 mg Gastro-resistant Tablets

Active Ingredient:
mycophenolic acid as mycophenolate sodium
Company:  
Sandoz Limited See contact details
ATC code: 
L04AA06
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Risk Materials Letters to HCPs
{arrow_left}
{arrow_right}

Important information for Healthcare Professionals

{pdf_link}

Ceptava 180 mg and 360 mg Gastro-resistant Tablets

{healthcare_pro_orange} For Healthcare Professionals

For batches PS9257 of Ceptava 180 mg Gastro-resistant Tablets and batches PU5715, PU5716 of Ceptava 360 mg Gastro-resistant Tablets, the current versions of the PIL included in the pack, as well as the Summary of Product Characteristics (SmPC) available on Electronic Medicines Compendium (EMC) website for Ceptava, do not yet reflect the latest safety updates. Therefore, the relevant information is being provided in this DHPC to ensure transparency and patient safety.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Sandoz Limited
Company image
Address
Maxis 1, Western Road, Bracknell, RG12 1RF, UK
WWW
http://www.sandoz.uk.com
WWW
https://pvi1j.solutions.iqvia.com
Telephone
+44 (0) 1276 698020
Medical Information Direct Line
+44 (0)1276 698 101
Medical Information e-mail
[email protected]
Adverse event reporting email
[email protected]
Customer Care direct line
+44 (0)1276 698020
E-mail
[email protected]
E-mail
[email protected]